Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 1/2011

Open Access 01.01.2011 | Brief Report

Clinical evaluation of Bio-Rad MRSASelect™ medium for the detection of livestock-associated methicillin-resistant Staphylococcus aureus

verfasst von: E. Verkade, C. Verhulst, B. van Cleef, J. Kluytmans

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 1/2011

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Bio-Rad MRSASelect™ medium was evaluated for its ability to recover methicillin-resistant Staphylococcus aureus (MRSA) from nasal samples of pig farmers and their household members. In total, 257 samples were inoculated on Bio-Rad MRSASelect™ medium with and without broth enrichment and on bioMérieux MRSA ID with broth enrichment. A sample was considered to be positive if at least one of the media grew MRSA. The sensitivity of Bio-Rad MRSASelect™ medium without broth enrichment was 63.9%. With broth enrichment, the sensitivity increased to 98.4%. The specificity was 95.4% both with and without broth enrichment. In conclusion, Bio-Rad MRSASelect™ medium as well as MRSA ID medium are reliable methods to detect MRSA carriage when used in combination with broth enrichment. The directly inoculated MRSASelect™ medium was statistically significantly less sensitive than the two media after broth enrichment.
First described in 1961, methicillin-resistant Staphylococcus aureus (MRSA) has emerged worldwide as a nosocomial pathogen of major importance, and the incidence of infections caused by MRSA continues to increase [1, 2]. Since the 1990s, MRSA has also emerged in the community [3]. In addition, a new clone has been identified, which is related to an extensive reservoir in animals. Persons who are in direct contact with pigs frequently carry this livestock-associated MRSA (LA-MRSA) [4, 5].
Laboratory-based screening for MRSA colonization of patients and health care workers remains a cornerstone of infection control measures to limit the spread of this organism [6]. Methods to detect MRSA in clinical samples should ideally have a high sensitivity and specificity, combined with a short time to reporting of the results. To identify S. aureus from contaminated samples more easily and reliably, selective media have been developed [7]. The extension of MRSA beyond its previously known boundaries to livestock-related persons poses a challenge for microbiological laboratories to improve their screening strategies. The purpose of this study is to evaluate the in vivo sensitivity and specificity of a new selective medium for the detection of MRSA from nasal samples taken from people living or working on pig farms.
MRSASelect™ is a chromogenic medium for the identification of MRSA in human specimens and was supplied as prepoured culture plates from Bio-Rad, Hercules, California, USA. The composition of the chromogenic and selective mix is proprietary. On MRSASelect™, MRSA strains form distinctive pink colonies. The selective mixture inhibits methicillin-susceptible S. aureus (MSSA) strains, most bacteria not belonging to the genus Staphylococcus, and yeasts. Results can be read after 18–28 h, according to the manufacturer.
Nasal samples were taken from pig farmers, their co-workers, and their household members as part of an ongoing study and sent by mail to the Laboratory for Microbiology and Infection Control at the Amphia Hospital, the Netherlands. Samples were inoculated onto MRSASelect™ medium and diluted with a sterile loop using a three-streak dilution method. In addition, a broth enrichment containing Mueller–Hinton broth with 6.5% NaCl was inoculated using the same swab, and this was incubated overnight at 35°C. Subsequently, 10 μl of the broth enrichment was inoculated onto both MRSASelect™ and MRSA ID (bioMérieux, La Balme Les Grottes, France). Both sets of plates were read after 18–28 h of incubation at 35–37°C. Growth of colonies on the MRSASelect™ agar plates showing pink coloration or growth of colonies with green coloration on the MRSA ID agar plates were considered to be indicative for MRSA. No growth or colonies with colors other than pink or green were considered to be negative. Presumptive S. aureus colonies were further identified by a latex agglutination test (Slidex™ Staph-Kit; bioMérieux, La Balme Les Grottes, France), and by the detection of DNase (Oxoid DNase agar; Thermo Fisher Scientific, Basingstoke, UK). When isolates were identified as S. aureus, the methicillin susceptibility was tested using the cefoxitin disk diffusion test according to the Clinical and Laboratory Standards Institute (CLSI; formerly the National Committee on Clinical Laboratory Standards [NCCLS]) standards [8]. All cefoxitin-resistant isolates were confirmed to be MRSA using a duplex polymerase chain reaction (PCR) assay for the mecA gene and the coagulase gene as described previously [9, 10], and this was considered to be the “gold standard.” When MRSA was recovered from one or more of the media, the sample was considered to be positive.
A total of 257 freshly collected nasal samples originating from different individuals were analyzed in this study. When combined results for all media were analyzed, 61 of the 257 (23.7%) samples were identified as positive for MRSA. The results obtained with MRSASelect™ medium and MRSA ID medium are shown in Table 1. When used in combination with broth enrichment, the sensitivity of MRSASelect™ was comparable to MRSA ID. The directly inoculated MRSASelect™ was statistically significantly less sensitive than the two media after broth enrichment. After broth enrichment, MRSASelect™ grew nine and MRSA ID grew ten false-positive strains. These false-positive strains were not further identified. This results in specificities of 95.4 and 94.9%, respectively (p = 1.0). The specificity of the directly inoculated MRSASelect™ medium was also 95.4%. In combination with broth enrichment, the positive predictive values (PPV) of MRSASelect™ and of MRSA ID were 87.0 and 85.9%, respectively (p = 1.0). The negative predictive values (NPV) were 99.5 and 100.0%, respectively (p = 1.0). The PPV and NPV of directly inoculated MRSASelect™ were 81.3 and 89.5%, respectively.
Table 1
Analytical performance of MRSASelect™ and MRSA ID medium in a prospective clinical study of nasal swabs (n = 257, including n = 61 MRSA-positive samples)
Medium
Method
True-positive
False-positive
Sensitivity %
Specificity %
PPV %
NPV %
MRSASelect
Direct
39
9
63.9
95.4
81.3
89.5
 
Enrichment
60
9
98.4
95.4
87.0
99.5
MRSA ID
Enrichment
61
10
100
94.9
85.9
100
PPV, positive predictive value; NPV, negative predictive value
We evaluated the in vivo performance of MRSASelect™ medium and MRSA ID medium with and without broth enrichment in a population with a high prevalence of MRSA carriage. Both media had high sensitivities and adequate specificities when used in combination with broth enrichment. However, without broth enrichment, the sensitivities were significantly lower. This confirms the importance of broth enrichment for the accurate detection of MRSA in clinical samples [11].
The sensitivity and specificity found in this clinical evaluation are significantly lower than recent findings in other studies [12, 13]. Stoakes et al. [12] compared MRSASelect™ medium with CHROMagar, mannitol-salt agar with oxacillin, and mannitol-salt agar with cefoxitin. In this study, nasal and perineal swabs were routinely collected from all patients admitted to the hospital who had been admitted to any health care facility in the previous 6 months. They processed a total of 2,125 (1,243 nasal and 882 perineal) consecutive swabs and found that three from the 111 confirmed MRSA strains were not detected by MRSASelect™ medium (sensitivity of 97.3%). Ben Nsira et al. [13] screened 666 samples using MRSASelect™ medium and three other selective media. Ninety-nine samples were positive for MRSA on at least one selective medium. Only one MRSA isolate was missed on MRSASelect™ medium (sensitivity of 99.8%). The discrepancy between the sensitivities obtained in these two studies in comparison to the direct plating in our study is most likely caused by the addition of broth enrichment in our culture procedure. This improves the sensitivity of the reference method substantially and, thereby, reduces the sensitivity of the test that is evaluated (in this case, the direct plating method). Another explanation for the discrepancy between the specificity found in our evaluation and in some other studies may be that we screened a specific population, i.e., pig farmers and their household members, who carry a specific clone of MRSA, namely, LA-MRSA, and these strains all belong to multilocus sequence type 398 (ST398) [4, 5, 16, 17]. Therefore, our results do not necessarily apply to other types of MRSA.
A study that reported similar results to our findings was performed by van Loo et al. [11]. In total, they tested 3,000 samples from 409 patients for the presence of MRSA. Every sample was directly inoculated onto an MRSASelect™ medium. Fifty-five out of 70 true-positive samples (sensitivity 78.6%) were detected by the MRSASelect™ medium after 48 h of incubation. Subsequently, the investigators subcultured 225 samples from a broth enrichment containing Mueller–Hinton broth with 6 μg/ml oxacillin and 6 μg/ml aztreonam on the MRSASelect™ medium. This increased the yield of MRSA containing samples by 12%. Our increase was much larger, which may be explained by the choice of the type of broth enrichment. However, the present study used a less selective broth enrichment than van Loo et al. A recent study found that the broth enrichment as used by van Loo et al. resulted in suboptimal performance [14].
In another recent study, Nonhoff et al. [15] evaluated the performance of three chromogenic media, MRSA ID, MRSA Screen, and MRSASelect™, in combination with broth enrichment for the detection of MRSA in 1,002 mucocutaneous swabs from 639 hospitalized patients. A sample was considered to be positive when MRSA was isolated from any of the three media tested. MRSA strains were isolated from 68 (6.8%) specimens from 44 patients. The sensitivity of all chromogenic media was <50% after 18 h of incubation, but increased with prolonged incubation at 42 h to 75, 80.9, and 72.1% for MRSA ID, MRSA Screen, and MRSASelect™, respectively. The difference in sensitivity between MRSA Screen and MRSASelect™ after 42 h was significant. After enrichment, the sensitivity for all media was 85.3% at 24 h of incubation. The specificity was excellent for MRSA ID (99.9%) and MRSASelect™ (100%) after 18 h, and lower for MRSA Screen (97.2%), albeit not statistically significantly so. This study confirms the additional yield of broth enrichment and is comparable to our findings. Comparison of the results of all the above-mentioned studies with our current evaluation is not easy because of differences in the study design: swab type, body site sampled, direct inoculation versus prior homogenization in saline or broth, incubation time, use or not of broth enrichment, and, most importantly, the nature of the test chosen as the gold standard.
The results of our study have one important limitation. We sampled a specific population, i.e., pig farmers, who carry a specific clone of MRSA, namely, LA-MRSA. Therefore, the performance may be different for other types of MRSA. There are several studies which reported that persons working with pigs frequently carry LA-MRSA [4, 16, 17]. van Loo et al. [4] performed a case–control study and showed that carriers of LA-MRSA were more often pig or cattle farmers. Thirty-four of 35 case-patients carried ST398; one had ST9. In addition, Wulf et al. [16] reported that veterinarians at an international conference on pig health frequently carried MRSA. Thirty-one of the 34 isolates were non-typeable by pulsed-field gel electrophoresis (PFGE) following SmaI digestion of chromosomal DNA. All of the non-typeable isolates belonged to spa types that correspond to ST398 (t011, t034, t108, t571, t567, and t899). Finally, van den Broek et al. [17] demonstrated that intensive and repeated exposure to pigs is an important factor in MRSA colonization and that this is almost always ST398. Although we did not perform molecular typing, it is beyond reasonable doubt that the vast majority of the MRSA strains recovered in our study belonged to ST398 . The conclusion is that MRSASelect™ medium and MRSA ID medium in combination with broth enrichment are useful tools for the detection of LA-MRSA in nasal samples. In this study, the MRSASelect™ medium and MRSA ID medium were equivalent and can be used indifferently. The additional yield of the broth enrichment was comparable to what has been reported previously and is considered to be the standard for screening of MRSA. After direct inoculation or subculture of broth enrichment, typical MRSA colonies need to be confirmed by further testing.

Acknowledgments

The chromogenic medium MRSASelect™ was kindly provided by Bio-Rad (Hercules, California, USA).

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Open AccessThis is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://​creativecommons.​org/​licenses/​by-nc/​2.​0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
download
DOWNLOAD
print
DRUCKEN

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Archer GL (1998) Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 26:1179–1181CrossRefPubMed Archer GL (1998) Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 26:1179–1181CrossRefPubMed
2.
Zurück zum Zitat Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Jacobson C, Smulders M, Gemmen E, Bharmal M (2007) National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998–2003). Clin Infect Dis 45:1132–1140CrossRefPubMed Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Jacobson C, Smulders M, Gemmen E, Bharmal M (2007) National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998–2003). Clin Infect Dis 45:1132–1140CrossRefPubMed
3.
Zurück zum Zitat Kluytmans-Vandenbergh MF, Kluytmans JA (2006) Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clin Microbiol Infect 12(Suppl 1):9–15CrossRefPubMed Kluytmans-Vandenbergh MF, Kluytmans JA (2006) Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clin Microbiol Infect 12(Suppl 1):9–15CrossRefPubMed
4.
Zurück zum Zitat van Loo I, Huijsdens X, Tiemersma E, de Neeling A, van de Sande-Bruinsma N, Beaujean D, Voss A, Kluytmans J (2007) Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis 13:1834–1839PubMed van Loo I, Huijsdens X, Tiemersma E, de Neeling A, van de Sande-Bruinsma N, Beaujean D, Voss A, Kluytmans J (2007) Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis 13:1834–1839PubMed
5.
Zurück zum Zitat Voss A, Loeffen F, Bakker J, Klaassen C, Wulf M (2005) Methicillin-resistant Staphylococcus aureus in pig farming. Emerg Infect Dis 11:1965–1966PubMed Voss A, Loeffen F, Bakker J, Klaassen C, Wulf M (2005) Methicillin-resistant Staphylococcus aureus in pig farming. Emerg Infect Dis 11:1965–1966PubMed
6.
Zurück zum Zitat Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM (2003) SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 24:362–386CrossRefPubMed Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM (2003) SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 24:362–386CrossRefPubMed
7.
Zurück zum Zitat Merlino J, Leroi M, Bradbury R, Veal D, Harbour C (2000) New chromogenic identification and detection of Staphylococcus aureus and methicillin-resistant S. aureus. J Clin Microbiol 38:2378–2380PubMed Merlino J, Leroi M, Bradbury R, Veal D, Harbour C (2000) New chromogenic identification and detection of Staphylococcus aureus and methicillin-resistant S. aureus. J Clin Microbiol 38:2378–2380PubMed
8.
Zurück zum Zitat National Committee for Clinical Laboratory Standards (NCCLS) (1997) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th edn. Approved standard M7-A4. NCCLS, Wayne, PA National Committee for Clinical Laboratory Standards (NCCLS) (1997) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th edn. Approved standard M7-A4. NCCLS, Wayne, PA
9.
Zurück zum Zitat Kluytmans JA, van Griethuysen A, Willemse P, van Keulen P (2002) Performance of CHROMagar selective medium and oxacillin resistance screening agar base for identifying Staphylococcus aureus and detecting methicillin resistance. J Clin Microbiol 40:2480–2482CrossRefPubMed Kluytmans JA, van Griethuysen A, Willemse P, van Keulen P (2002) Performance of CHROMagar selective medium and oxacillin resistance screening agar base for identifying Staphylococcus aureus and detecting methicillin resistance. J Clin Microbiol 40:2480–2482CrossRefPubMed
10.
Zurück zum Zitat van Griethuysen AJ, Pouw M, van Leeuwen N, Heck M, Willemse P, Buiting A, Kluytmans J (1999) Rapid slide latex agglutination test for detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol 37:2789–2792PubMed van Griethuysen AJ, Pouw M, van Leeuwen N, Heck M, Willemse P, Buiting A, Kluytmans J (1999) Rapid slide latex agglutination test for detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol 37:2789–2792PubMed
11.
Zurück zum Zitat van Loo IH, van Dijk S, Verbakel-Schelle I, Buiting AG (2006) Evaluation of a chromogenic agar (MRSASelect) for the detection of meticillin-resistant Staphylococcus aureus with clinical samples in The Netherlands. J Med Microbiol 56:491–494 van Loo IH, van Dijk S, Verbakel-Schelle I, Buiting AG (2006) Evaluation of a chromogenic agar (MRSASelect) for the detection of meticillin-resistant Staphylococcus aureus with clinical samples in The Netherlands. J Med Microbiol 56:491–494
12.
Zurück zum Zitat Stoakes L, Reyes R, Daniel J, Lennox G, John MA, Lannigan R, Hussain Z (2006) Prospective comparison of a new chromogenic medium, MRSASelect, to CHROMagar MRSA and mannitol-salt medium supplemented with oxacillin or cefoxitin for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 44:637–639CrossRefPubMed Stoakes L, Reyes R, Daniel J, Lennox G, John MA, Lannigan R, Hussain Z (2006) Prospective comparison of a new chromogenic medium, MRSASelect, to CHROMagar MRSA and mannitol-salt medium supplemented with oxacillin or cefoxitin for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 44:637–639CrossRefPubMed
13.
Zurück zum Zitat Ben Nsira S, Dupuis M, Leclercq R (2006) Evaluation of MRSASelect, a new chromogenic medium for the detection of nasal carriage of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 27:561–564CrossRefPubMed Ben Nsira S, Dupuis M, Leclercq R (2006) Evaluation of MRSASelect, a new chromogenic medium for the detection of nasal carriage of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 27:561–564CrossRefPubMed
14.
Zurück zum Zitat Böcher S, Smyth R, Kahlmeter G, Kerremans J, Vos MC, Skov R (2008) Evaluation of four selective agars and two enrichment broths in screening for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 46:3136–3138CrossRefPubMed Böcher S, Smyth R, Kahlmeter G, Kerremans J, Vos MC, Skov R (2008) Evaluation of four selective agars and two enrichment broths in screening for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 46:3136–3138CrossRefPubMed
15.
Zurück zum Zitat Nonhoff C, Denis O, Brenner A, Buidin P, Legros N, Thiroux C, Dramaix M, Struelens MJ (2009) Comparison of three chromogenic media and enrichment broth media for the detection of methicillin-resistant Staphylococcus aureus from mucocutaneous screening specimens: comparison of MRSA chromogenic media. Eur J Clin Microbiol Infect Dis 28:363–369CrossRefPubMed Nonhoff C, Denis O, Brenner A, Buidin P, Legros N, Thiroux C, Dramaix M, Struelens MJ (2009) Comparison of three chromogenic media and enrichment broth media for the detection of methicillin-resistant Staphylococcus aureus from mucocutaneous screening specimens: comparison of MRSA chromogenic media. Eur J Clin Microbiol Infect Dis 28:363–369CrossRefPubMed
16.
Zurück zum Zitat Wulf MW, Sørum M, van Nes A, Skov R, Melchers WJ, Klaassen CH, Voss A (2008) Prevalence of methicillin-resistant Staphylococcus aureus among veterinarians: an international study. Clin Microbiol Infect 14:29–34CrossRefPubMed Wulf MW, Sørum M, van Nes A, Skov R, Melchers WJ, Klaassen CH, Voss A (2008) Prevalence of methicillin-resistant Staphylococcus aureus among veterinarians: an international study. Clin Microbiol Infect 14:29–34CrossRefPubMed
17.
Zurück zum Zitat van den Broek IV, van Cleef BA, Haenen A, Broens EM, van der Wolf PJ, van den Broek MJ, Huijsdens XW, Kluytmans JA, van de Giessen AW, Tiemersma EW (2009) Methicillin-resistant Staphylococcus aureus in people living and working in pig farms. Epidemiol Infect 137:700–708CrossRef van den Broek IV, van Cleef BA, Haenen A, Broens EM, van der Wolf PJ, van den Broek MJ, Huijsdens XW, Kluytmans JA, van de Giessen AW, Tiemersma EW (2009) Methicillin-resistant Staphylococcus aureus in people living and working in pig farms. Epidemiol Infect 137:700–708CrossRef
Metadaten
Titel
Clinical evaluation of Bio-Rad MRSASelect™ medium for the detection of livestock-associated methicillin-resistant Staphylococcus aureus
verfasst von
E. Verkade
C. Verhulst
B. van Cleef
J. Kluytmans
Publikationsdatum
01.01.2011
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 1/2011
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-1035-7

Weitere Artikel der Ausgabe 1/2011

European Journal of Clinical Microbiology & Infectious Diseases 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.